Cardio Risks of Weight-Loss Combo Downplayed

ASH 2011 — NEW YORK CITY — There does not appear to be an overall increase in cardiovascular risk associated with the investigational weight-loss combination of controlled-release phentermine and topiramate (Qnexa), an analysis of three randomized trials showed.


< Back to Listings